These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio. Pediconi F, Fraioli F, Catalano C, Napoli A, Danti M, Francone M, Venditti F, Nardis P, Passariello R. Radiol Med; 2003 Jul; 106(1-2):87-93. PubMed ID: 12951555 [Abstract] [Full Text] [Related]
10. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases]. Wang QJ, Wang Y, Xu X, Xiao H, Ma L. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693 [Abstract] [Full Text] [Related]
11. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV. Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [Abstract] [Full Text] [Related]
12. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver]. Zhang HM, Ouyang H, Zhou CW. Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014 [Abstract] [Full Text] [Related]